2009/2010 Conditional license for E. coli cattle vaccine in the U.S. 2009/2010 Achievement of pre-commercialization milestone payments for UrocidinTM 2010 First U.S. sales of E. coli cattle vaccine 2010 Results of refractory Phase III NMI bladder cancer trial 23 2011 Belleville, ON vaccine manufacturing centre operational